You just read:

NICE Expands Recommendation for the Oncotype DX Breast Recurrence Score® Test to More Patients with Early-Stage Breast Cancer Within the United Kingdom

News provided by

Genomic Health, Inc.

Dec 19, 2018, 08:00 ET